TAK1 inhibitors (OSI Pharmaceuticals)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTAK1 inhibitors (OSI Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTGF-β activated kinase-1 inhibitors
TargetsTGF-β activated kinase-1
Therapy Area/IndicationsOvarian NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsi Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsi Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A